You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Harvard Business School
Mallinckrodt
Moodys
Johnson and Johnson

Last Updated: February 19, 2020

DrugPatentWatch Database Preview

Details for Patent: 6,180,639


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,180,639
Title: 1,3-oxathiolane nucleoside analogues
Abstract:(-)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one, its pharmaceutically acceptable derivatives, pharmaceutical formulation thereof, methods for its preparation and its uses as an antiviral agent are described.
Inventor(s): Coates; Jonathan Allan (Greenford, GB), Mutton; Ian Martin (Greenford, GB), Penn; Charles Richard (Greenford, GB), Williamson; Christopher (Greenford, GB), Storer; Richard (Greenford, GB)
Assignee: BioChem Pharma Inc. (Laval, CA)
Application Number:07/835,964
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;

Drugs Protected by US Patent 6,180,639

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,180,639

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9009861May 02, 1990
PCT Information
PCT FiledMay 02, 1991PCT Application Number:PCT/GB91/00706
PCT Publication Date:November 14, 1991PCT Publication Number: WO91/17159

International Family Members for US Patent 6,180,639

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 182   Start Trial
African Regional IP Organization (ARIPO) 9100255   Start Trial
Australia 651345   Start Trial
Australia 7771991   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Express Scripts
AstraZeneca
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.